Cell Therapy News/Articles, page-16776

Global pharma conglomerates are always looking to expand their pipelines all the time - one only has to look at Roche's CEO's comments today and of course we know their current R & D pipeline includes Heart Failure ... I think we are vulnerable down here so I guess we are lucky that Gregory and Silviu have such a large holding between them ... GLTAH



https://endpts.com/roche-ceo-outlines-new-rd-strategy-after-years-of-late-stage-trial-failures/


Roche CEO outlines new R&D strategy after years of late-stage trial failures


New Roche CEO Thomas Schinecker is implementing a refined R&D strategy for the sprawling Swiss conglomerate in the wake of several recent late-stage failures.

The new goals aim to ensure pipeline programs can move more efficiently from early-stage to late-stage, while the company also hunts for deals on drugs already being tested in human trials, Schinecker said Monday during Roche’s Pharma Day in London.

“We need to deliver value fast, and that’s the mentality we want in the organization,” the CEO said.